JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LORENZETTI, O. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LORENZETTI, O. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 175, Issue 3, 763-772, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics

EFFECTS OF CORTICOSTEROIDS ON OCULAR DYNAMICS IN RABBITS

O. J. LORENZETTI 1

1 Miles Labs, Inc., Therapeutic Research Laboratories, Elkhart, Indiana

Elevated intraocular pressure (IOP) has been produced in rabbits upon chronic instillation of corticosteroids. These steroid-induced elevated IOP's were concentration-dependent and were followed by the known systemic toxic effects consisting of weight loss, polyuria, polydipsia and frequent deaths depending on the concentration instilled. The severity of the elevated IOP produced by twice daily instillation of corticosteroids was concentration-dependent as well as dependent on the type of corticosteroid instilled. In this study dexamethasone 21-phosphate and betamethasone 17-valerate produced the severest elevations of IOP in rabbits, whereas hydrocortisone and 11beta-hydroxy-6agr-methylpregn-4-ene-3,20-dione (medrysone) produced moderate elevation. Approximately three-fourths of the treated animals responded to corticosteroid instillation with IOP elevations, with the responding animals exhibiting various degrees of severity in elevated IOP. The elevated IOP could be reversed by discontinuation of steroid instillation as well as by adrenergic drugs and carbonic anhydrase inhibitors. The IOP effects paralleled the anti-inflammatory potency of the steroids, and all of the steroids evaluated exhibited IOP elevation upon chronic instillation.

Submitted on February 26, 1970
Accepted on August 10, 1970




This article has been cited by other articles:


Home page
 IOVSHome page
A. F. Clark, H. T. Steely, J. E. Dickerson Jr, S. English-Wright, K. Stropki, M. D. McCartney, N. Jacobson, A. R. Shepard, J. I. Clark, H. Matsushima, et al.
Glucocorticoid Induction of the Glaucoma Gene MYOC in Human and Monkey Trabecular Meshwork Cells and Tissues
Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1769 - 1780.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. H. Fingert, A. F. Clark, J. E. Craig, W. L. M. Alward, G. R. Snibson, M. McLaughlin, L. Tuttle, D. A. Mackey, V. C. Sheffield, and E. M. Stone
Evaluation of the Myocilin (MYOC) Glaucoma Gene in Monkey and Human Steroid-Induced Ocular Hypertension
Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 145 - 152.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Melena, J. Santafé, and J. Segarra
The Effect of Topical Diltiazem on the Intraocular Pressure in Betamethasone-Induced Ocular Hypertensive Rabbits
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 278 - 282.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.